Cortisol as a Target for Treating Mental Disorders: A Promising Avenue for Therapy
- PMID: 37861053
- DOI: 10.2174/0113895575262104230928042150
Cortisol as a Target for Treating Mental Disorders: A Promising Avenue for Therapy
Abstract
Cortisol, commonly known as the "stress hormone," plays a critical role in the body's response to stress. Elevated cortisol levels have been associated with various mental disorders, including anxiety, depression, and post-traumatic stress disorder. Consequently, researchers have explored cortisol modulation as a promising avenue for treating these conditions. However, the availability of research on cortisol as a therapeutic option for mental disorders is limited, and existing studies employ diverse methodologies and outcome measures. This review article aimed to provide insights into different treatment approaches, both pharmacological and non-pharmacological, which can effectively modulate cortisol levels. Pharmacological interventions involve the use of substances, such as somatostatin analogs, dopamine agonists, corticotropin-releasing hormone antagonists, and cortisol synthesis inhibitors. Additionally, non-pharmacological techniques, including cognitivebehavioral therapy, herbs and supplements, transcranial magnetic stimulation, lifestyle changes, and surgery, have been investigated to reduce cortisol levels. The emerging evidence suggests that cortisol modulation could be a promising treatment option for mental disorders. However, more research is needed to fully understand the effectiveness and safety of these therapies.
Keywords: Cortisol; anxiety; depression; mental disorders; non-pharmacological interventions.; pharmacological interventions.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
References
-
- Nijsten K.; van der Minnen L.M.; Dean C.; Bais J.M.J.; Ris-Stalpers C.; van Eekelen R.; Bremer H.A.; van der Ham D.P.; Heidema W.M.; Huisjes A.; Kleiverda G.; Kuppens S.M.; van Laar J.O.E.H.; Langenveld J.; van der Made F.; Papatsonis D.; Pelinck M.J.; Pernet P.J.; van Rheenen-Flach L.; Rijnders R.J.; Scheepers H.C.J.; Vogelvang T.; Mol B.W.; Olff M.; Roseboom T.J.; Koot M.H.; Grooten I.J.; Painter R.C.; Depression, anxiety, and post-traumatic stress disorder symptoms after hyperemesis gravidarum: A prospective cohort study. J Matern Fetal Neonatal Med 2022,35(25),10055-10063 - DOI - PubMed
-
- Junaedi F.; Hanurawan F.; Setiowati A.J.; Ramli M.; Reducing the new inmates’ anxiety through rational emotive behavior therapy with patronage counseling technique. Emerg Sci J 2022,6(2),306-321 - DOI
-
- Sankova M.V.; Kytko O.V.; Vasil’ev Y.L.; Aleshkina O.Y.; Diachkova E.Y.; Darawsheh H.M.; Kolsanov A.V.; Dydykin S.S.; Medical students’ reactive anxiety as a quality criterion for distance learning during the sars-cov-2 pandemic. Emer Sci J 2021,5,86-93 - DOI
-
- Thau L.; Gandhi J.; Sharma S.; Physiology, CortisolStatPearls 2022
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
